 | • レポートコード：D005-06430 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、女性用避妊薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。女性用避妊薬の種類別市場規模（避妊薬、避妊具）、用途別市場規模（個人、病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Lupin Pharmaceuticals、Mylan、Mayer Laboratories、Johnson & Johnson、Pfizer、Fuji Latex、Merck、Teva、Female Health Company ・地域別グローバル市場分析 2015年-2020年 ・女性用避妊薬の北米市場（アメリカ、カナダ、メキシコ） ・女性用避妊薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・女性用避妊薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・女性用避妊薬の南米市場（ブラジル、アルゼンチン） ・女性用避妊薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：避妊薬、避妊具 ・用途別分析：個人、病院 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Female Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Female Contraceptives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Female Contraceptives market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Female Contraceptives market has been segmented into
Contraceptive Drugs
Contraceptive Devices
By Application, Female Contraceptives has been segmented into:
Personal use
Hospital
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Female Contraceptives market presented in the report. This section sheds light on the sales growth of different regional and country-level Female Contraceptives markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Female Contraceptives market.
The report offers in-depth assessment of the growth and other aspects of the Female Contraceptives market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Female Contraceptives Market Share Analysis
Female Contraceptives competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Female Contraceptives sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Female Contraceptives sales, revenue and market share for each player covered in this report.
The major players covered in Female Contraceptives are:
Bayer
Lupin Pharmaceuticals
Mylan
Mayer Laboratories
Johnson & Johnson
Pfizer
Fuji Latex
Merck
Teva
Female Health Company
Among other players domestic and global, Female Contraceptives market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Female Contraceptives product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Female Contraceptives, with price, sales, revenue and global market share of Female Contraceptives in 2018 and 2019.
Chapter 3, the Female Contraceptives competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Female Contraceptives breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Female Contraceptives market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Female Contraceptives sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Female Contraceptives Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Female Contraceptives Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Contraceptive Drugs
1.2.3 Contraceptive Devices
1.3 Market Analysis by Application
1.3.1 Overview: Global Female Contraceptives Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Personal use
1.3.3 Hospital
1.4 Overview of Global Female Contraceptives Market
1.4.1 Global Female Contraceptives Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lupin Pharmaceuticals
2.2.1 Lupin Pharmaceuticals Details
2.2.2 Lupin Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lupin Pharmaceuticals SWOT Analysis
2.2.4 Lupin Pharmaceuticals Product and Services
2.2.5 Lupin Pharmaceuticals Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mylan SWOT Analysis
2.3.4 Mylan Product and Services
2.3.5 Mylan Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mayer Laboratories
2.4.1 Mayer Laboratories Details
2.4.2 Mayer Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mayer Laboratories SWOT Analysis
2.4.4 Mayer Laboratories Product and Services
2.4.5 Mayer Laboratories Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Fuji Latex
2.7.1 Fuji Latex Details
2.7.2 Fuji Latex Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Fuji Latex SWOT Analysis
2.7.4 Fuji Latex Product and Services
2.7.5 Fuji Latex Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva SWOT Analysis
2.9.4 Teva Product and Services
2.9.5 Teva Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Female Health Company
2.10.1 Female Health Company Details
2.10.2 Female Health Company Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Female Health Company SWOT Analysis
2.10.4 Female Health Company Product and Services
2.10.5 Female Health Company Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Female Contraceptives Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Female Contraceptives Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Female Contraceptives Manufacturer Market Share in 2019
3.3.2 Top 6 Female Contraceptives Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Female Contraceptives Sales, Revenue and Market Share by Regions
4.1.1 Global Female Contraceptives Sales and Market Share by Regions (2015-2020)
4.1.2 Global Female Contraceptives Revenue and Market Share by Regions (2015-2020)
4.2 North America Female Contraceptives Sales and Growth Rate (2015-2020)
4.3 Europe Female Contraceptives Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Female Contraceptives Sales and Growth Rate (2015-2020)
4.5 South America Female Contraceptives Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Female Contraceptives Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Female Contraceptives Sales, Revenue and Market Share by Country
5.1.1 North America Female Contraceptives Sales and Market Share by Country (2015-2020)
5.1.2 North America Female Contraceptives Revenue and Market Share by Country (2015-2020)
5.2 United States Female Contraceptives Sales and Growth Rate (2015-2020)
5.3 Canada Female Contraceptives Sales and Growth Rate (2015-2020)
5.4 Mexico Female Contraceptives Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Female Contraceptives Sales, Revenue and Market Share by Country
6.1.1 Europe Female Contraceptives Sales and Market Share by Country (2015-2020)
6.1.2 Europe Female Contraceptives Revenue and Market Share by Country (2015-2020)
6.2 Germany Female Contraceptives Sales and Growth Rate (2015-2020)
6.3 UK Female Contraceptives Sales and Growth Rate (2015-2020)
6.4 France Female Contraceptives Sales and Growth Rate (2015-2020)
6.5 Russia Female Contraceptives Sales and Growth Rate (2015-2020)
6.6 Italy Female Contraceptives Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Female Contraceptives Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Female Contraceptives Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Female Contraceptives Revenue and Market Share by Regions (2015-2020)
7.2 China Female Contraceptives Sales and Growth Rate (2015-2020)
7.3 Japan Female Contraceptives Sales and Growth Rate (2015-2020)
7.4 Korea Female Contraceptives Sales and Growth Rate (2015-2020)
7.5 India Female Contraceptives Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Female Contraceptives Sales and Growth Rate (2015-2020)
7.7 Australia Female Contraceptives Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Female Contraceptives Sales, Revenue and Market Share by Country
8.1.1 South America Female Contraceptives Sales and Market Share by Country (2015-2020)
8.1.2 South America Female Contraceptives Revenue and Market Share by Country (2015-2020)
8.2 Brazil Female Contraceptives Sales and Growth Rate (2015-2020)
8.3 Argentina Female Contraceptives Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Female Contraceptives Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Female Contraceptives Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Female Contraceptives Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Female Contraceptives Sales and Growth Rate (2015-2020)
9.3 Turkey Female Contraceptives Sales and Growth Rate (2015-2020)
9.4 Egypt Female Contraceptives Sales and Growth Rate (2015-2020)
9.5 South Africa Female Contraceptives Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Female Contraceptives Sales and Market Share by Type (2015-2020)
10.2 Global Female Contraceptives Revenue and Market Share by Type (2015-2020)
10.3 Global Female Contraceptives Price by Type (2015-2020)
11 Global Female Contraceptives Market Segment by Application
11.1 Global Female Contraceptives Sales Market Share by Application (2015-2020)
11.2 Global Female Contraceptives Revenue Market Share by Application (2015-2020)
11.3 Global Female Contraceptives Price by Application (2015-2020)
12 Market Forecast
12.1 Global Female Contraceptives Sales, Revenue and Growth Rate (2021-2025)
12.2 Female Contraceptives Market Forecast by Regions (2021-2025)
12.2.1 North America Female Contraceptives Market Forecast (2021-2025)
12.2.2 Europe Female Contraceptives Market Forecast (2021-2025)
12.2.3 Asia-Pacific Female Contraceptives Market Forecast (2021-2025)
12.2.4 South America Female Contraceptives Market Forecast (2021-2025)
12.2.5 Middle East & Africa Female Contraceptives Market Forecast (2021-2025)
12.3 Female Contraceptives Market Forecast by Type (2021-2025)
12.3.1 Global Female Contraceptives Sales Forecast by Type (2021-2025)
12.3.2 Global Female Contraceptives Market Share Forecast by Type (2021-2025)
12.4 Female Contraceptives Market Forecast by Application (2021-2025)
12.4.1 Global Female Contraceptives Sales Forecast by Application (2021-2025)
12.4.2 Global Female Contraceptives Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Female Contraceptives Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Female Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Female Contraceptives Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Female Contraceptives Major Business
Table 9. Bayer Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 10. Bayer SWOT Analysis
Table 11. Bayer Female Contraceptives Product and Services
Table 12. Bayer Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Lupin Pharmaceuticals Female Contraceptives Major Business
Table 15. Lupin Pharmaceuticals Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 16. Lupin Pharmaceuticals SWOT Analysis
Table 17. Lupin Pharmaceuticals Female Contraceptives Product and Services
Table 18. Lupin Pharmaceuticals Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Female Contraceptives Major Business
Table 21. Mylan Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 22. Mylan SWOT Analysis
Table 23. Mylan Female Contraceptives Product and Services
Table 24. Mylan Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Mayer Laboratories Basic Information, Manufacturing Base and Competitors
Table 26. Mayer Laboratories Female Contraceptives Major Business
Table 27. Mayer Laboratories Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 28. Mayer Laboratories SWOT Analysis
Table 29. Mayer Laboratories Female Contraceptives Product and Services
Table 30. Mayer Laboratories Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Female Contraceptives Major Business
Table 33. Johnson & Johnson Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 34. Johnson & Johnson SWOT Analysis
Table 35. Johnson & Johnson Female Contraceptives Product and Services
Table 36. Johnson & Johnson Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Female Contraceptives Major Business
Table 39. Pfizer Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Female Contraceptives Product and Services
Table 42. Pfizer Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Fuji Latex Basic Information, Manufacturing Base and Competitors
Table 44. Fuji Latex Female Contraceptives Major Business
Table 45. Fuji Latex Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 46. Fuji Latex SWOT Analysis
Table 47. Fuji Latex Female Contraceptives Product and Services
Table 48. Fuji Latex Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck Basic Information, Manufacturing Base and Competitors
Table 50. Merck Female Contraceptives Major Business
Table 51. Merck Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 52. Merck SWOT Analysis
Table 53. Merck Female Contraceptives Product and Services
Table 54. Merck Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Teva Basic Information, Manufacturing Base and Competitors
Table 56. Teva Female Contraceptives Major Business
Table 57. Teva Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 58. Teva SWOT Analysis
Table 59. Teva Female Contraceptives Product and Services
Table 60. Teva Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Female Health Company Basic Information, Manufacturing Base and Competitors
Table 62. Female Health Company Female Contraceptives Major Business
Table 63. Female Health Company Female Contraceptives Total Revenue (USD Million) (2017-2018)
Table 64. Female Health Company SWOT Analysis
Table 65. Female Health Company Female Contraceptives Product and Services
Table 66. Female Health Company Female Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Female Contraceptives Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Female Contraceptives Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Female Contraceptives Sales by Regions (2015-2020) (K Units)
Table 70. Global Female Contraceptives Sales Market Share by Regions (2015-2020)
Table 71. Global Female Contraceptives Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Female Contraceptives Sales by Countries (2015-2020) (K Units)
Table 73. North America Female Contraceptives Sales Market Share by Countries (2015-2020)
Table 74. North America Female Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Female Contraceptives Revenue Market Share by Countries (2015-2020)
Table 76. Europe Female Contraceptives Sales by Countries (2015-2020) (K Units)
Table 77. Europe Female Contraceptives Sales Market Share by Countries (2015-2020)
Table 78. Europe Female Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Female Contraceptives Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Female Contraceptives Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Female Contraceptives Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Female Contraceptives Sales by Countries (2015-2020) (K Units)
Table 83. South America Female Contraceptives Sales Market Share by Countries (2015-2020)
Table 84. South America Female Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Female Contraceptives Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Female Contraceptives Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Female Contraceptives Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Female Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Female Contraceptives Revenue Market Share by Countries (2015-2020)
Table 90. Global Female Contraceptives Sales by Type (2015-2020) (K Units)
Table 91. Global Female Contraceptives Sales Share by Type (2015-2020)
Table 92. Global Female Contraceptives Revenue by Type (2015-2020) (USD Million)
Table 93. Global Female Contraceptives Revenue Share by Type (2015-2020)
Table 94. Global Female Contraceptives Sales by Application (2015-2020) (K Units)
Table 95. Global Female Contraceptives Sales Share by Application (2015-2020)
Table 96. Global Female Contraceptives Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Female Contraceptives Market Share Forecast by Regions (2021-2025)
Table 98. Global Female Contraceptives Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Female Contraceptives Market Share Forecast by Type (2021-2025)
Table 100. Global Female Contraceptives Sales Forecast by Application (2021-2025)
Table 101. Global Female Contraceptives Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Female Contraceptives Picture
Figure 2. Global Sales Market Share of Female Contraceptives by Type in 2019
Figure 3. Contraceptive Drugs Picture
Figure 4. Contraceptive Devices Picture
Figure 5. Female Contraceptives Sales Market Share by Application in 2018
Figure 6. Personal use Picture
Figure 7. Hospital Picture
Figure 8. Global Female Contraceptives Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Female Contraceptives Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Female Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Female Contraceptives Sales Market Share by Manufacturer in 2019
Figure 29. Global Female Contraceptives Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Female Contraceptives Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Female Contraceptives Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Female Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Female Contraceptives Revenue Market Share by Regions (2015-2020)
Figure 36. Global Female Contraceptives Revenue Market Share by Regions in 2018
Figure 37. North America Female Contraceptives Sales and Growth Rate (2015-2020)
Figure 38. Europe Female Contraceptives Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Female Contraceptives Sales and Growth Rate (2015-2020)
Figure 40. South America Female Contraceptives Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Female Contraceptives Sales and Growth Rate (2015-2020)
Figure 42. North America Female Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Female Contraceptives Sales Market Share by Countries (2015-2020)
Figure 44. North America Female Contraceptives Sales Market Share by Countries in 2018
Figure 45. North America Female Contraceptives Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Female Contraceptives Revenue Market Share by Countries in 2018
Figure 47. United States Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Female Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Female Contraceptives Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Female Contraceptives Revenue Market Share by Countries in 2019
Figure 53. Germany Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Female Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Female Contraceptives Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Female Contraceptives Revenue Market Share by Regions 2019
Figure 61. China Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Female Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Female Contraceptives Sales Market Share by Countries in 2019
Figure 68. South America Female Contraceptives Revenue Market Share by Countries in 2019
Figure 69. Brazil Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Female Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Female Contraceptives Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Female Contraceptives Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Female Contraceptives Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Female Contraceptives Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Female Contraceptives Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Female Contraceptives Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Female Contraceptives Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Female Contraceptives Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Female Contraceptives Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Female Contraceptives Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Female Contraceptives Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
避妊薬＆器具の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Contraceptives Drugs and Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.5% in the forecast period of 2020 to 2025 and will expected to reach USD 24150 million by 2025, from USD 18110 million in 2019. The Contr…- 緊急避妊薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Emergency Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Emergency Contracept…
- 配合経口避妊薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combined Hormonal Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 20710 million by 2025, from USD 18300 million in 2019. The Combi…
- 女性用滅菌装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Female Sterilization Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Female Steriliza…
- 女性用ストレス尿失禁治療装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Female Stress Urinary Incontinence Treatment Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…